Actinium Pharmaceuticals Inc (ATNM)
6.91
+0.35
(+5.34%)
USD |
NYAM |
Apr 26, 16:00
6.80
-0.11
(-1.59%)
After-Hours: 20:00
Actinium Pharmaceuticals Cash from Investing (TTM): -0.153M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.153M |
| September 30, 2023 | -0.169M |
| June 30, 2023 | -0.212M |
| March 31, 2023 | -0.435M |
| December 31, 2022 | -0.366M |
| September 30, 2022 | -0.35M |
| June 30, 2022 | -0.345M |
| March 31, 2022 | -0.136M |
| December 31, 2021 | -0.133M |
| September 30, 2021 | -0.378M |
| June 30, 2021 | -0.318M |
| March 31, 2021 | -0.257M |
| December 31, 2020 | -0.253M |
| September 30, 2020 | -0.013M |
| June 30, 2020 | -0.005M |
| March 31, 2020 | -0.013M |
| December 31, 2019 | -0.064M |
| September 30, 2019 | -0.0696M |
| June 30, 2019 | -0.1283M |
| March 31, 2019 | -0.1401M |
| December 31, 2018 | -0.0961M |
| September 30, 2018 | -0.0868M |
| June 30, 2018 | -0.0348M |
| March 31, 2018 | -0.0234M |
| December 31, 2017 | -0.0247M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0407M |
| June 30, 2017 | -0.0352M |
| March 31, 2017 | -0.0407M |
| December 31, 2016 | -0.1098M |
| September 30, 2016 | -0.1134M |
| June 30, 2016 | -0.1382M |
| March 31, 2016 | -0.1252M |
| December 31, 2015 | -0.0478M |
| September 30, 2015 | -0.0625M |
| June 30, 2015 | -0.0589M |
| March 31, 2015 | -0.1847M |
| December 31, 2014 | -0.1864M |
| September 30, 2014 | -0.1594M |
| June 30, 2014 | -0.1439M |
| March 31, 2014 | -0.0172M |
| December 31, 2013 | -0.0166M |
| September 30, 2013 | -0.0086M |
| June 30, 2013 | -0.0023M |
| March 31, 2013 | -0.0023M |
| December 31, 2012 | -0.0024M |
| September 30, 2012 | 0.0232M |
| June 30, 2012 | 0.0238M |
| March 31, 2012 | -0.0012M |
| December 31, 2011 | 0.00 |
| September 30, 2011 | -0.025M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.435M
Minimum
Mar 2023
-0.005M
Maximum
Jun 2020
-0.1999M
Average
-0.169M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
| Perspective Therapeutics Inc | 24.37M |
| Eli Lilly and Co | -7.153B |
| Cellectar Biosciences Inc | -0.864M |
| Bristol-Myers Squibb Co | -2.295B |
| Oragenics Inc | -0.9363M |